Highlights Aptorum Group Limited

Equities

APM

KYG6096M1226

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
4.99 ^USD	-0.20%		-10.57%	+103.79%

04-30	Aptorum Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-06	Top Midday Gainers	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aptorum Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	04-30	CI
YOOV Group Holding Limited entered into a entered into an Agreement and Plan of Merger to acquire Aptorum Group Limited for $250 million in a reverse merger transaction.	03-05	CI
Aptorum Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	12-22	CI
Aptorum Group Obtains Nasdaq Authorization to Transfer Listing to Nasdaq Capital Market	10/08/23	MT
Aptorum Group Limited Provides Updates on a Phase 1b/2a Clinical Trial for Repurposed Small Molecule Drug SACT-1 for Neuroblastoma	22/06/23	CI
Aptorum Group Gets Non-Compliance Notice From Nasdaq -- Shares Slump in Premarket	08/05/23	MT
Aptorum Group Gets Non-Compliance Notice From Nasdaq	08/05/23	MT
Aptorum Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23	CI
Aptorum, URF Holding Group to Combine in Reverse Takeover	27/03/23	MT
URF Holding Group Limited entered into a non-binding Letter of Intent and Term Sheet to acquire Aptorum Group Limited for $40 million in a reverse merger transaction.	26/03/23	CI
Aptorum Group Completes US FDA Meetings for ALS-4, SACT-1	03/03/23	MT
Aptorum Group Announces Completion of Pre-IND Discussions with US FDA on Its ALS-4	03/03/23	CI
Aptorum Group Announces Completion of End of Phase 1 Meeting with US FDA on Its Sact-1	03/03/23	CI
Aptorum Group Launches NativusWell, a Novel Nutraceutical for Menopause, in China	02/03/23	CI
Aptorum Group Regains Compliance With Nasdaq Minimum Bid Price Rule But Gets New Deficiency Notice	13/02/23	MT
Aptorum Group Sets 1-for-10 Reverse Stock Split for Monday; Shares Rise Pre-Bell	20/01/23	MT
Aptorum Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022	30/09/22	CI
Aptorum Group Limited Updates on the Clinical Validation of RPIDD Infectious Disease Liquid Biopsy Molecular Diagnostics	15/09/22	CI
Aptorum Group Limited Launches NativusWell, a Novel Nutraceutical for Menopause, in Hong Kong	15/09/22	CI
Aptorum Group Limited Updates on Data from Completed Phase 1 Clinical Trial of SACT-1, Targeting Neuroblastoma	02/05/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Aptorum Group Limited

Equities

APM

KYG6096M1226

Highlights

Filters